Aquatic Capital Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,500
Closed -$74K 1636
2022
Q3
$74K Buy
21,500
+18,300
+572% +$70K 0.01% 827
2022
Q2
$9K Buy
3,200
+2,700
+540% +$14.2K ﹤0.01% 981
2022
Q1
$4K Buy
500
+200
+67% +$2.21K 0.01% 873
2021
Q4
$5K Buy
+300
New +$5.65K 0.01% 948

Other funds holding MGNX

Aquatic Capital Management's MGNX Position: Q4 2022 in Review

Aquatic Capital Management sold out of MacroGenics (MGNX) in Q4 2022, closing a stake of 21,500 shares — an estimated $74K sold.

Aquatic Capital Management first reported a position in MGNX in Q4 2021 and held it in 4 quarters. The position peaked at $74K in Q3 2022. 135 funds tracked by Wall St. Rank hold MGNX as of Q4 2022.

  • Aquatic Capital Management reported no remaining MacroGenics position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 21,500 MacroGenics shares in Q4 2022, an estimated $74K.
  • Aquatic Capital Management first reported a position in MacroGenics in Q4 2021 and held it in 4 quarters.
  • Aquatic Capital Management's MacroGenics position peaked at $74K in Q3 2022.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.